By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

F1 Oncology Inc. 

505 S Flagler Drive

West Palm Beach  Florida    U.S.A.
Phone: 858-200-5193 Fax: n/a


SEARCH JOBS

F1 Oncology, Inc. is a private Delaware C corporation formed in November 2015 with operations in West Palm Beach, Florida, San Diego, California and international affiliates in George Town, Cayman Islands, Hong Kong, and Shanghai, China. F1 Oncology was founded by Gregory Frost, Ph.D., co-founder and former CEO of Halozyme Therapeutics Inc., Health Sector Chief at Intrexon Corporation, and current managing director of F1 BioVentures, LLC, a biotechnology-focused investment vehicle. F1 Oncology leverages its globally integrated science, development and informatics teams located across multiple time zones to accelerate the design, high-throughput screening, discovery and development of adoptive cellular therapy candidates. The company is developing two CAB-based ACT platforms to develop TME restricted CAR-T therapies for solid tumors, as well as developing highly scalable systems for global deployment, beginning in Asia.

YEAR FOUNDED:

2016

LEADERSHIP:

CEO: Gregory I. Frost, Ph.D.


Key Statistics


Email:
Ownership: Private

Web Site: F1 Oncology
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
//-->